688131 皓元医药
2025/06 - 中期
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(10,431)381,960(63,606)(240,233)57,835
投资活动产生之现金流量净额270,460(783,654)(328,511)(713,002)(305,839)
筹资活动产生之现金流量净额186,879791,479409,209360,3241,007,294
汇率变动对现金及现金等价物的影响14,3307,8453,11114,415(7,242)
现金及现金等价物净增加/(减少)461,237397,63020,202(578,496)752,047
期初现金及现金等价物余额873,096475,466455,2641,033,760281,713
期末现金及现金等价物余额1,334,333873,096475,466455,2641,033,760